BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26329581)

  • 41. An architectural map of the anaphase-promoting complex.
    Thornton BR; Ng TM; Matyskiela ME; Carroll CW; Morgan DO; Toczyski DP
    Genes Dev; 2006 Feb; 20(4):449-60. PubMed ID: 16481473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The E3 ligase Cdh1-anaphase promoting complex operates upstream of the E3 ligase Smurf1 in the control of axon growth.
    Kannan M; Lee SJ; Schwedhelm-Domeyer N; Stegmüller J
    Development; 2012 Oct; 139(19):3600-12. PubMed ID: 22949615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does APC/C
    Dohrn MF; Bolaños JP
    J Neurochem; 2019 Oct; 151(1):8-10. PubMed ID: 31441503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pax3 function is required specifically for inner ear structures with melanogenic fates.
    Kim H; Ankamreddy H; Lee DJ; Kong KA; Ko HW; Kim MH; Bok J
    Biochem Biophys Res Commun; 2014 Mar; 445(3):608-14. PubMed ID: 24565836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The anaphase-promoting complex works together with the SCF complex for proteolysis of the S-phase cyclin Clb6 during the transition from G1 to S phase.
    Wu SY; Kuan VJ; Tzeng YW; Schuyler SC; Juang YL
    Fungal Genet Biol; 2016 Jun; 91():6-19. PubMed ID: 26994663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
    Kubic JD; Little EC; Lui JW; Iizuka T; Lang D
    Oncogene; 2015 Sep; 34(38):4964-74. PubMed ID: 25531327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription.
    Dong L; Li Y; Cao J; Liu F; Pier E; Chen J; Xu Z; Chen C; Wang RA; Cui R
    Cell Death Differ; 2012 Apr; 19(4):616-22. PubMed ID: 21997191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anaphase-promoting complex/cyclosome-cdh1 mediates the ubiquitination and degradation of TRB3.
    Ohoka N; Sakai S; Onozaki K; Nakanishi M; Hayashi H
    Biochem Biophys Res Commun; 2010 Feb; 392(3):289-94. PubMed ID: 20064487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter.
    Galibert MD; Yavuzer U; Dexter TJ; Goding CR
    J Biol Chem; 1999 Sep; 274(38):26894-900. PubMed ID: 10480898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulation of α-Melanocyte-Stimulating Hormone-Induced Activation of the Pax3-MITF-Tyrosinase Axis by Sorghum Ethanolic Extract in B16F10 Melanoma Cells.
    Lee DH; Ahn SS; Kim JB; Lim Y; Lee YH; Shin SY
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29865165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Destruction box-dependent degradation of aurora B is mediated by the anaphase-promoting complex/cyclosome and Cdh1.
    Stewart S; Fang G
    Cancer Res; 2005 Oct; 65(19):8730-5. PubMed ID: 16204042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaphase-Promoting Complex Adaptor FZR1/CDH1 Blocks BRAF Signaling Both by Targeting BRAF for Proteolytic Degradation and by Disrupting BRAF Dimerization.
    Zhang C; Bollag G
    Cancer Discov; 2017 Apr; 7(4):356-358. PubMed ID: 28373167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pax3( GFP ) , a new reporter for the melanocyte lineage, highlights novel aspects of PAX3 expression in the skin.
    Djian-Zaouche J; Campagne C; Reyes-Gomez E; Gadin-Czerw S; Bernex F; Louise A; Relaix F; Buckingham M; Panthier JJ; Aubin-Houzelstein G
    Pigment Cell Melanoma Res; 2012 Sep; 25(5):545-54. PubMed ID: 22621661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cdc20 proteolysis requires p38 MAPK signaling and Cdh1-independent APC/C ubiquitination during spindle assembly checkpoint activation by cadmium.
    Yen AH; Yang JL
    J Cell Physiol; 2010 May; 223(2):327-34. PubMed ID: 20054826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation.
    Lu H; Liu B; Zhang FJ; Zhang J; Dong R; Chen L; Qu DM; Lu Y; Yu BW
    Cell Cycle; 2014; 13(24):3892-902. PubMed ID: 25483061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of APC(Cdh1) E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7.
    Lau AW; Inuzuka H; Fukushima H; Wan L; Liu P; Gao D; Sun Y; Wei W
    Cell Res; 2013 Jul; 23(7):947-61. PubMed ID: 23670162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.
    Kubic JD; Lui JW; Little EC; Ludvik AE; Konda S; Salgia R; Aplin AE; Lang D
    J Biol Chem; 2015 Sep; 290(36):21901-14. PubMed ID: 26205821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PAX3 and SOX10 activate MET receptor expression in melanoma.
    Mascarenhas JB; Littlejohn EL; Wolsky RJ; Young KP; Nelson M; Salgia R; Lang D
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):225-37. PubMed ID: 20067553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. APC/Cdh1 targets PECAM-1 for ubiquitination and degradation in endothelial cells.
    Liu J; Yao Q; Xiao L; Li F; Ma W; Zhang Z; Xie X; Yang C; Cui Q; Tian Y; Zhang C; Lai B; Wang N
    J Cell Physiol; 2020 Mar; 235(3):2521-2531. PubMed ID: 31489637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell cycle oscillators underlying orderly proteolysis of E2F8.
    Wasserman D; Nachum S; Cohen M; Enrico TP; Noach-Hirsh M; Parasol J; Zomer-Polak S; Auerbach N; Sheinberger-Chorni E; Nevenzal H; Levi-Dadon N; Wang X; Lahmi R; Michaely E; Gerber D; Emanuele MJ; Tzur A
    Mol Biol Cell; 2020 Apr; 31(8):725-740. PubMed ID: 31995441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.